🇺🇸 MMRvaxpro in United States
6 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 6
Most-reported reactions
- Breech Presentation — 1 report (16.67%)
- Bronchiolitis — 1 report (16.67%)
- Hip Dysplasia — 1 report (16.67%)
- Maternal Drugs Affecting Foetus — 1 report (16.67%)
- Thelitis — 1 report (16.67%)
- Transient Tachypnoea Of The Newborn — 1 report (16.67%)
Other Immunology / Infectious Disease approved in United States
Frequently asked questions
Is MMRvaxpro approved in United States?
MMRvaxpro does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for MMRvaxpro in United States?
Rigshospitalet, Denmark is the originator. The local marketing authorisation holder may differ — check the official source linked above.